| Product Code: ETC7605325 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Communicable Diseases Treatment Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Communicable Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Iraq Communicable Diseases Treatment Market - Industry Life Cycle |
3.4 Iraq Communicable Diseases Treatment Market - Porter's Five Forces |
3.5 Iraq Communicable Diseases Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Iraq Communicable Diseases Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Iraq Communicable Diseases Treatment Market Revenues & Volume Share, By Infectious Agent, 2021 & 2031F |
3.8 Iraq Communicable Diseases Treatment Market Revenues & Volume Share, By Mode of Transmission, 2021 & 2031F |
3.9 Iraq Communicable Diseases Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 Iraq Communicable Diseases Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Iraq Communicable Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of communicable diseases in Iraq |
4.2.2 Government initiatives to improve healthcare infrastructure |
4.2.3 Growing awareness about preventive healthcare measures |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas |
4.3.2 High cost of treatment and medications |
4.3.3 Lack of trained healthcare professionals |
5 Iraq Communicable Diseases Treatment Market Trends |
6 Iraq Communicable Diseases Treatment Market, By Types |
6.1 Iraq Communicable Diseases Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Gastroenteritis, 2021- 2031F |
6.1.4 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Gonorrhoea, 2021- 2031F |
6.1.5 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Whooping Cough, 2021- 2031F |
6.1.6 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Common Cold, 2021- 2031F |
6.1.7 Iraq Communicable Diseases Treatment Market Revenues & Volume, By HIV/AIDS, 2021- 2031F |
6.1.8 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Pink Eye, 2021- 2031F |
6.1.9 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Iraq Communicable Diseases Treatment Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.3 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2.4 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.2.5 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.2.6 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.2.7 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Antiparasitics, 2021- 2031F |
6.2.8 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Iraq Communicable Diseases Treatment Market, By Infectious Agent |
6.3.1 Overview and Analysis |
6.3.2 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Bacteria, 2021- 2031F |
6.3.3 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Viruses, 2021- 2031F |
6.3.4 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Fungi/Parasites, 2021- 2031F |
6.4 Iraq Communicable Diseases Treatment Market, By Mode of Transmission |
6.4.1 Overview and Analysis |
6.4.2 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Direct Contact, 2021- 2031F |
6.4.3 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Person-to-person Contact, 2021- 2031F |
6.4.4 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Droplet Spread, 2021- 2031F |
6.4.5 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4.6 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Indirect Contact, 2021- 2031F |
6.4.7 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Airborne Transmission, 2021- 2031F |
6.4.8 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.4.9 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.5 Iraq Communicable Diseases Treatment Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Sexually Transmitted Diseases, 2021- 2031F |
6.5.3 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Helminthic Diseases, 2021- 2031F |
6.5.4 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Contact Communicable Diseases, 2021- 2031F |
6.5.5 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Oral Contamination Diseases, 2021- 2031F |
6.5.6 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Air Borne Diseases, 2021- 2031F |
6.6 Iraq Communicable Diseases Treatment Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Iraq Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Iraq Communicable Diseases Treatment Market Import-Export Trade Statistics |
7.1 Iraq Communicable Diseases Treatment Market Export to Major Countries |
7.2 Iraq Communicable Diseases Treatment Market Imports from Major Countries |
8 Iraq Communicable Diseases Treatment Market Key Performance Indicators |
8.1 Percentage of population covered by healthcare facilities |
8.2 Number of awareness campaigns conducted by the government or NGOs |
8.3 Mortality rate due to communicable diseases in Iraq |
9 Iraq Communicable Diseases Treatment Market - Opportunity Assessment |
9.1 Iraq Communicable Diseases Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Iraq Communicable Diseases Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Iraq Communicable Diseases Treatment Market Opportunity Assessment, By Infectious Agent, 2021 & 2031F |
9.4 Iraq Communicable Diseases Treatment Market Opportunity Assessment, By Mode of Transmission, 2021 & 2031F |
9.5 Iraq Communicable Diseases Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 Iraq Communicable Diseases Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Iraq Communicable Diseases Treatment Market - Competitive Landscape |
10.1 Iraq Communicable Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 Iraq Communicable Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here